Described is a process for making a dry and stable hemostatic composition said process comprising a) providing a first component comprising a dry preparation of a coagulation inducing agent b) providing a second component comprising a dry preparation of a biocompatible polymer suitable for use in hemostasis c) mixing said first component and said second component under conditions effective to form a wet paste while essentially preventing degradation of the second component by said first component in a final container or transferring said wet paste into a final container d) freezing and lyophilizing said paste in said container thereby obtaining a dry and stable hemostatic composition comprising said first and said second component in lyophilized form and e) finishing said dry and stable hemostatic composition in said final container to a storable pharmaceutical device containing said first component and said second component in a combined form as a dry and stable hemostatic composition.
